ResMed announced ResMed’s board of directors has appointed chief executive officer Michael Farrell as chair of the board, effective January 25. Farrell succeeds current chair Peter Farrell who will become chair emeritus and will remain an active board member. Mick Farrell became ResMed’s CEO on March 1, 2013, and has served as a member of the company’s board of directors since assuming that role.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RMD:
- ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
- ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
- ResMed upgraded to Buy at Citi as Philips CPAP recall drags on
- ResMed upgraded to Buy from Neutral at Citi
- ResMed upgraded to Overweight from Neutral at JPMorgan
